|Product Name||Arthrogen-CIA® 5-Clone Cocktail Kit, 100 mg|
|Quantity||100 mg (*65 mice)|
Mouse CAIA Protocol
Arthrogen-CIA® arthritogenic monoclonal antibody 5 clones cocktail kit (100 mg, 10 mg/ml x 10 ml) + LPS
L. Danks, N. Komatsu, M. Guerrini, S. Sawa, M. Armaka, et al., RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis 75, 1187-95 (2016).
F. Biscetti, A. Flex, G. Pecorini, F. Angelini, V. Arena, et al., The role of highâ€mobility group box protein 1 in collagen antibodyâ€induced arthritis is dependent on vascular endothelial growth factor . Clin Exp Immunol 184, 62-72 (2016).
Y. Matsuo, F. Mizoguchi, T. Saito, K. Kawahata, S. Ueha, et al., Local fibroblast proliferation but not influx is responsible for synovial hyperplasia in a murine model of rheumatoid arthritis. Biochem Biophys Res Commun 470, 504-9 (2016).
J. Ishikawa, N. Takahashi, T. Matsumoto, Y. Yoshioka, N. Yamamoto, et al., Factors secreted from dental pulp stem cells show multifaceted benefits for treating experimental rheumatoid arthritis. Bone 83, 210-9 (2016).
S. Atkinson, U. Hoffmann, A. Hamann, E. Bach, N. Danneskiold-Samsøe, et al., Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis inC57BL/6 mice that can be counteracted by IL-17 blockade. Dis Model Mech 9, 427-40 (2016).
S. Fukumitsu, M. Villareal, T. Fujitsuka, K. Aida, H. Isoda, et al., Anti-inflammatory and anti-arthritic effects of pentacyclic triterpenoids maslinic acid through NF-κBinactivation. Mol Nutr Food Res 60, 399-409 (2016).
H. Park, K. Sandor, J. McQueen, S. Woller, C. Svensson, et al., The effect of gabapentin and ketorolac on allodynia and conditioned place preference in antibody-induced inflammation. Eur J Pain 20, 917-25 (2016).
J. Peng, S. Chen, C. Wu, H. Chong, Y. Ding, et al., Amelioration of Experimental Autoimmune Arthritis Through Targeting of Synovial Fibroblasts by Intraarticular Delivery of MicroRNAs 140-3p and 140-5p. Arthritis Rheumatol 68, 370-81 (2016).
M. Cantley, D. Fairlie, P. Bartold, V. Marino, P. Gupta, D. Haynes, et al., Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis. Rheumatology (Oxford) 54, 1713-23 (2015).
E. Perilli, M. Cantley, V. Marino, T. Crotti, M. Smith, et al., Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomography. Scand J Immunol 81, 142-50 (2015).
E. Rossato, M. Ben, Y. Kanamaru, M. Hurtado-Nedelec, G. Hayem, et al., Reversal of arthritis by human monomeric IgA through receptor mediated SHP-1 inhibitory pathway. Arthritis Rheumatol 67, 1766-77 (2015).
T. Endo, K. Ito, J. Morimoto, M. Kanayama, D. Ota, et al., Syndecan-4 regulates the development of autoimmune arthritis by modulating B cell migration and germinal center formation. Arthritis Rheumatol 67, 2512-22 (2015).
S. Atkinson, A. Nansen, P. Usher, B. Sondergaard, C. Mackay, et al., Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model. Autoimmunity 48, 460-70 (2015).
J. Lee, E. Hong, H. Jeong, J. Hwang, H. Kim, et al., A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model. Int J Rheum Dis 18, 514-23 (2015).
M. Donoviel, N. Hait, S. Ramachandran, M. Maceyka, K. Takabe, et al., Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases. FASEB J 29, 5018-28 (2015).
N. Gully, R. Bright, V. Marino, C. Marchant, M. Cantley, et al., Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS One 9, e100838 (2014).
M. Drutskaya, G. Efimov, R. Zvartsev, A. Chashchina, D. Chudakov, et al., Experimental models of arthritis in which pathogenesis is dependent on TNF expression. Biochemistry (Mosc) 79, 1349-57 (2014).
M. Ebbesen, K. Bienk, B. Deleuran, K. Howard, Extended blood circulation and joint accumulation of a p(HPMA-co-AzMA)-based nanoconjugate in a murine model of rheumatoid arthritis. Mol Cell Ther 2, 9 (2014).
N. Agalave, M. Larsson, S. Abdelmoaty, J. Su, A. Baharpoor, et al., Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis. Pain 155, 1802-13 (2014).
S. Kon, Y. Nakayama, N. Matsumoto, K. Ito, M. Kanayama, et al., A Novel Cryptic Binding Motif, LRSKSRSFQVSDEQY, in the C-Terminal Fragment of MMP-3/7-Cleaved Osteopontin as a Novel Ligand for a9ß1 Integrin Is Involved in the Anti-Type II Collagen Antibody-Induced Arthritis. PLoS One 9, e116210 (2014).
I. Campbell, S. Miescher, D. Branch, P. Mott, A. Lazarus, et al., Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J Immunol 192, 5031-8 (2014).
A. Abd-Allah, S. Ahmad, I. Alrashidi, H. Abdel-Hamied, K. Zoheir, et al., Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis. Int Immunol 26, 325-40 (2014).
R. Zhao, N. Chen, X. Zhou, P. Miao, C. Hu, et al., Exogenous IFN-beta regulates the RANKL-c-FosIFN-beta signaling pathway in the collagen antibody-induced arthritis model. J Transl Med 12, 330 (2014).
S. Funato, A. Matsunaga, K. Oh, Y. Miyamoto, K. Yoshimura, et al., Effects of antibody to receptor activator of nuclear factor ?-B ligand on inflammation and cartilage degradation in collagen antibody-induced arthritis in mice. J Negat Results Biomed 13, 18 (2014).
G. Mehta, V. Ferreira, C. Skerka, P. Zipfel, N. Banda, New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases. Mol Immunol 62, 235-48 (2014).
R. Zhao, N. Chen, X. Zhou, P. Miao, C. Hu, et al., Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model. J Transl Med 12, 330 (2014).
B. Crielaard, C. Rijcken, L. Quan, d. van, I. Altintas, et al., Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis. Angew Chem Int Ed Engl 51, 7254-8 (2012).
D. Xu, Y. Kim, J. Postelnek, M. Vu, D. Hu, et al., RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents. J Pharmacol Exp Ther 341, 90-103 (2012).
T. Chiba, Y. Matsuzaka, T. Warita, T. Sugoh, K. Miyashita, et al., NFKBIL1 Confers Resistance to Experimental Autoimmune Arthritis Through the Regulation of Dendritic Cell Functions. Scand J Immunol 73, 478-85 (2011).
V. Willis, A. Gizinski, N. Banda, C. Causey, B. Knuckley, et al., N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 186, 4396-404 (2011).
J. Kong, S. Yoo, H. Kim, H. Kim, K. Yea, et al., Inhibition of Synovial Hyperplasia, Rheumatoid T Cell Activation, and Experimental Arthritis in Mice by Sulforaphane, a Naturally Occurring Isthiocyanate. Arthritis Rheum 62, 159-70 (2010).
J. Minaguchi, T. Oohashi, K. Inagawa, A. Ohtsuka, Y. Ninomiya, Transvascular accumulation of Sialyl Lewis X conjugated liposome in inflamed joints of collagen antibody-induced arthritic (CAIA) mice. Arch Histol Cytol 71, 195-203 (2008).
|53010||Arthrogen-CIA® 5-Clone Cocktail Kit, 10 mg Cocktail of 5-monoclonal antibodies against moues type II collagen for in vivo use to induce experimental mouse model of arthritis (Collagen Antibody-Induced Arthritis/CAIA). Other sizes of product available (cat# 53100, 53040)||$699.00||Add To Cart|
|53040||Arthrogen-CIA® 5-Clone Cocktail Kit, 40 mg Cocktail of 5 monoclonal antibodies specific for mouse type II collagen. For in vivo use to induce experimental arthritis model (Collagen Antibody-Induced Arthritis/CAIA). Other sizes available (cat# 53010, 53100).||$2700.00||Add To Cart|